CO15 | Longitudinal coagulation profiling of individuals undergoing gender-affirming hormone therapy: the hyper-gender study

Background and Aims: Transgender individuals appear to have an increased risk of thrombosis due to hypercoagulability associated with gender-affirming hormone therapy (GAHT). The aim of the study was to investigate the effects of GAHT on coagulation, metabolism, and erythropoiesis, and to explore t...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-08-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://www.btvb.org/btvb/article/view/219
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items